(Total Views: 697)
Posted On: 07/19/2020 5:39:15 PM
Post# of 154138
Patterson definitely has some conflicts of interest.
For example, Patterson recently filed a patent on the use of RANTES as a diagnostic indicator for leronlimab in covid19.
If Patterson's patent proves dispositive, the patent could dictate the leronlimab dosing schedule in covid19.
No doubt Cytodyn prefers not to have Patterson's patent regulating dosing schedules in covid19.
For example, Patterson recently filed a patent on the use of RANTES as a diagnostic indicator for leronlimab in covid19.
If Patterson's patent proves dispositive, the patent could dictate the leronlimab dosing schedule in covid19.
No doubt Cytodyn prefers not to have Patterson's patent regulating dosing schedules in covid19.
(1)
(0)
